Patients wanted for study - the world's largest treatment study of chronic tinnitus at the Charité Berlin.

Monday, 10/05/2021

After a year of hard work, the UNITI study, which is part of the EU-funded UNITI project, started in mid-April. So far, 26 suitable patients have been found for the study. This number is too small to generate reliable statements. The goal is to include a total of 100 patients in the study and to treat them after randomisation.

The Tinnitus Centre of the Charité, Universitätsmedizin Berlin is currently looking for patients between 18 and 80 years of age with chronic tinnitus who would like to participate in a clinical study to investigate the effectiveness of single or combination treatments for tinnitus.

The clinical study UNITI (Unification of Treatments and Interventions for Tinnitus Patients), which is funded by the European Union, is the largest clinical study on tinnitus to date and is being conducted at four other clinical centres in a total of four countries (Germany (Berlin & Regensburg), Belgium, Greece, Spain) in addition to the Tinnitus Centre of the Charité.

The aim of this study is to find out which patient groups benefit most from which treatment methods. The data from the clinical study will be combined with genetic data, medical and audiological examinations and existing databases to develop a computer model that predicts the best possible therapy. The combination of several treatment methods will also be systematically tested for the first time.

The following treatment methods will be used: wearing a hearing aid if indicated, cognitive behavioural therapy, structured psychological counselling and psychoeducation (via app), sound therapy (via app). Interested patients between the ages of 18 and 80 with chronic tinnitus (for at least six months) should be willing to use special applications on their smartphones and to regularly attend certain study visits and treatment appointments at the study centre at the Charité in Berlin at the Mitte Campus.

Patients interested in participating in the study should contact the UNITI study team by email at charite.uniti(at) or register directly for the so-called pre-screening at